基本信息
浏览量:21
职业迁徙
个人简介
Paolo Michieli was born in 1964 in Milano, Italy. From 1988 to 1990 he worked as an undergraduate student in the Laboratory of Molecular Biology of the Mario Negri Institute for Pharmacological Research in Milano, under the supervision of Dr. Enrico Garattini. In 1990 he graduated in Biological Sciences at the University of Milano with the highest grade (110/110 cum laude). After graduation he was awarded a fellowship from the Italian Association for Cancer Research (AIRC) to work on tumor suppressor genes at the Istituto Nazionale dei Tumori, Milano, in the group directed by Dr. Marco Pierotti. In 1992, after a short period of training at the Glaxo Research Laboratories in Verona, Italy, he moved to the United States to continue his research in the field of oncology. From 1992 to 196 he conducted research as a Visiting Fellow in the Laboratory of Cellular and Molecular Biology of the National Cancer Institute, National Institutes of Health (Bethesda, MD), in the group headed by Dr. Stuart Aaronson. During his stay at the NIH he contributed to several scientific publications in the field of oncogenes, growth factors and cell cycle. In 1997 he moved back to Italy to the newly founded Candiolo Institute for Cancer Research and Treatment (now Candiolo Cancer Institute, FPO-IRCCS) in Candiolo, Torino, directed by Prof. Paolo Comoglio. Since then he has been Group Leader of a small team committed to experimenting novel therapeutic strategies in the fields of oncology and regenerative medicine, with particular reference to the molecular targeting of growth factors and their receptors. Together with his group he developed several therapeutic molecules including engineered cytokines and monoclonal antibodies. In 2001 he specialized in Clinical Pathology at the University of Torino Medical School with the highest grade (70/70 cum laude). In 2008 he received a PhD in Cellular Sciences and Technologies from the same institution and in December 2011 he was appointed tenured Assistant Professor at the Department of Oncology. From 2007 to 2010 he started up directed the Center for Comparative Oncology, an animal facility dedicated to oncological research within the Candiolo Cancer Institute. In 2016, moved by entrepreneurial spirit, he founded EuremAb Srl, a University of Torino spin-off biotech company specialized in products and services in the regenerative medicine field. In 2017 he founded AgomAb Therapeutics, a Belgian biotech company focusing on growth factor therapeutics. In 2020 he moved his lab to the Molecular Biotechnology Center of the University of Torino to fully dedicate his efforts to drug discovery in the field of regenerative medicine. Today, he splits his time among three major activities: Tenured Researcher (Assistant Professor) at the University of Torino; Chief Operating Officer at EuremAb; and Chief Scientific Officer at AgomAb Therapeutics. He is author of 44 peer-reviewed publications with 5,001 citations, accounting for an H factor of 28. He is inventor of 69 patent applications and 45 granted patents.
研究兴趣
论文共 487 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Giorgia Migliardi, Francesco Sassi,Davide Torti,Francesco Galimi,Eugenia R. Zanella,Michela Buscarino,Dario Ribero, Andrea Muratore,Paolo Massucco, Alberto Pisacane,Mauro Risio,Lorenzo Capussotti,Silvia Marsoni,Federica Di Nicolantonio,Alberto Bardelli,Paolo M. Comoglio,Livio Trusolino,Andrea Bertotti
openalex(2023)
crossref(2023)
Giorgia Migliardi, Francesco Sassi,Davide Torti,Francesco Galimi,Eugenia R. Zanella,Michela Buscarino,Dario Ribero, Andrea Muratore, Paolo Massucco, Alberto Pisacane,Mauro Risio,Lorenzo Capussotti,Silvia Marsoni,Federica Di Nicolantonio,Alberto Bardelli,Paolo M. Comoglio,Livio Trusolino,Andrea Bertotti
openalex(2023)
Cristina Migliore,Valentina Martin, Vera P. Leoni,Angelo Restivo,Luigi Atzori, Annalisa Petrelli,Claudio Isella,Luigi Zorcolo, Ivana Sarotto, Giuseppe Casula,Paolo M. Comoglio,Amedeo Columbano,Silvia Giordano
openalex(2023)
crossref(2023)
加载更多
作者统计
#Papers: 487
#Citation: 35665
H-Index: 100
G-Index: 182
Sociability: 7
Diversity: 0
Activity: 2
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn